by Annie De Groot | May 24, 2017 | Featured, News, Thinking Out Loud -Blog
A new article in Nature Scientific Reports (doi: 10.1038/s41598-017-01372-5) entitled A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines may explain why H7N9 influenza vaccines are consistently less immunogenic in humans...
by Annie De Groot | Mar 7, 2017 | Featured, News, Thinking Out Loud -Blog
“Insanity: doing the same thing over and over again and expecting different results.” – Albert Einstein. Due to its high rate of lethality (30-40%) and pandemic potential, H7N9 preparedness has become a priority for public health officials. While...
by Annie De Groot | Feb 20, 2017 | Events, News
Lucky us! the 14th International Bio Asia Conference is scheduled for March 14-15, 2017 at the Grand Hyatt, Tokyo in Roppongi. It might be a bit early for cherry blossoms, but hope springs eternal! We will be arriving a bit early and staying a bit late. Please let us...
by Annie De Groot | Sep 12, 2016 | Featured, News
September 6, 2016 (Providence, RI) – EpiVax, Inc., “immune engineering” pioneer, has won a new $600,000 National Institutes of Health grant under the Small Business Innovation Research (SBIR) program to improve a vaccine for the problematic H7N9 avian influenza virus....
by Annie De Groot | Feb 14, 2016 | News, Thinking Out Loud -Blog
As a Valentine’s day gift to women at risk of Zika everywhere, we’re providing access to our initial analysis of Zika and our opinion on Zika vaccine design. If you just want access to the slides, here they are: https://bit.ly/Zika_Slides_EpiVax_2016...